Jain PharmaBiotech Publishes New Report on Antiviral Therapeutics

Published: May 15, 2007

BASEL, Switzerland--(BUSINESS WIRE)--Jain PharmaBiotech has announced the publication of a New Report " Antiviral Therapeutics - Technologies, Markets & Companies". This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The role of several technologies such as monoclonal antibodies, gene therapy, antisense and RNAi is discussed. Nanobiotechnology plays an important role in construction of viricidal agents as well as in improving delivery of antivirals. Expert opinion is given about the current problems and needs in antiviral therapy. SWOT (strengths, weaknesses, opportunities and threats) analysis of antiviral approaches is presented against the background of concept of an ideal antiviral agent. Focus is on influenza, HIV/AIDS, and hepatitis but other virus infections are also described.

Back to news